sonrotoclax
Generic: Sonrotoclax
sonrotoclax: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| BeOne Medicines Ltd. (ONC) | Phase 3 |
Clinical Trials (1)
An Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of the BCL2 Inhibitor Sonrotoclax (BGB-11417) as Monotherapy and in Combination With Zanubrutinib (BGB-3111) in Patients With Waldenström Macroglobulinemia
Frequently asked questions
Who is developing sonrotoclax?
sonrotoclax is being developed by BeOne Medicines Ltd..
How many clinical trials involve sonrotoclax?
BioSniper tracks 1 clinical trial involving sonrotoclax.
Get deeper analysis on sonrotoclax
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis